Legal Representation
Attorney
Keith R. Obert
USPTO Deadlines
Application History
19 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Dec 23, 2025 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
| Dec 23, 2025 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Nov 4, 2025 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Nov 4, 2025 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Oct 29, 2025 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Oct 3, 2025 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Sep 5, 2025 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Sep 4, 2025 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Sep 4, 2025 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Aug 8, 2025 | RFNT | P | REFUSAL PROCESSED BY IB | Loading... |
| Jul 24, 2025 | RFCS | P | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | Loading... |
| Jul 24, 2025 | RFRR | P | REFUSAL PROCESSED BY MPU | Loading... |
| May 30, 2025 | RFCR | E | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | Loading... |
| May 29, 2025 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| May 21, 2025 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Feb 23, 2025 | MAFR | O | APPLICATION FILING RECEIPT MAILED | Loading... |
| Feb 23, 2025 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Feb 19, 2025 | LIMI | I | LIMITATION FROM ORIGINAL APPLICATION ENTERED | Loading... |
| Feb 6, 2025 | REPR | M | SN ASSIGNED FOR SECT 66A APPL FROM IB | Loading... |
Detailed Classifications
Class 005
Tumor suppressing agents; vaccines; reagent paper for medical purposes; immunostimulants; adjuvants for medical purposes; diagnostic preparations for medical purposes
Class 042
Research and development of vaccines and medicines; vaccine research and development services; research and development services relating to medicines; consultancy relating to pharmaceutical research and development; development of pharmaceutical preparations and medicines; testing of pharmaceuticals; providing information about medical and scientific research in the field of pharmaceuticals; pharmaceutical product evaluation; medical research; biological research; scientific research; research and development of new products for others
Additional Information
Design Mark
The mark consists of a circle carrier with a border consisting of two concentric circles. Inside the circle carrier is an outline of a woman's portrait in profile, with her arm outstretched towards a heart design with rays of light emanating from the heart.
Classification
International Classes
005
042